The use of interleukin-1-receptor antagonists in the treatment of diabetes mellitus

Nat Clin Pract Endocrinol Metab. 2008 May;4(5):240-1. doi: 10.1038/ncpendmet0783. Epub 2008 Mar 4.
No abstract available

MeSH terms

  • Adipokines / blood
  • C-Reactive Protein / analysis
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / metabolism
  • Glycated Hemoglobin A / analysis
  • Humans
  • Injections, Subcutaneous
  • Insulin / blood
  • Insulin Resistance / physiology
  • Insulin-Secreting Cells / drug effects
  • Insulin-Secreting Cells / metabolism
  • Interleukin 1 Receptor Antagonist Protein / administration & dosage*
  • Interleukin-6 / blood
  • Proinsulin / blood
  • Randomized Controlled Trials as Topic
  • Receptors, Interleukin-1 / antagonists & inhibitors*

Substances

  • Adipokines
  • Glycated Hemoglobin A
  • Insulin
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-6
  • Receptors, Interleukin-1
  • C-Reactive Protein
  • Proinsulin